Mito
Member
- Joined
- Dec 10, 2016
- Messages
- 2,554
“A study on lung cancer patients found that activating the immune system can prompt tumours into spreading friendly T-cells around the body, significantly reducing the chance of cancer returning after surgery.”
“Scientists have hailed the new approach, called “cancer interception”, a “game-changer” potentially capable of stopping the disease in its tracks.”
“Teams are now setting out to trial the method on patients with blood, colon and ovarian cancers in what could be the start of a fundamental shift in treatment of the disease.”
“Oncologists at Johns Hopkins University and the Memorial Sloan Kettering Cancer Center administered the immunotherapy drug nivolumab over several weeks to 21 patients with non-small-cell lung cancer prior to surgery.”
“They found the strategy was not only safe, but that 45 per cent of the patients responded so well there was little evidence of the cancer remaining upon follow-up examinations.”
“Overall, recurrence-free survival at 18 months was 73 per cent.”
“This is compared to a roughly 50 per cent current clinical average.”
Immunotherapy-first cancer treatment a 'game-changer', say scientists
“Scientists have hailed the new approach, called “cancer interception”, a “game-changer” potentially capable of stopping the disease in its tracks.”
“Teams are now setting out to trial the method on patients with blood, colon and ovarian cancers in what could be the start of a fundamental shift in treatment of the disease.”
“Oncologists at Johns Hopkins University and the Memorial Sloan Kettering Cancer Center administered the immunotherapy drug nivolumab over several weeks to 21 patients with non-small-cell lung cancer prior to surgery.”
“They found the strategy was not only safe, but that 45 per cent of the patients responded so well there was little evidence of the cancer remaining upon follow-up examinations.”
“Overall, recurrence-free survival at 18 months was 73 per cent.”
“This is compared to a roughly 50 per cent current clinical average.”
Immunotherapy-first cancer treatment a 'game-changer', say scientists
